"Even a large dilution event now would be preferable if the money for a couple of years can be raised. This pipeline vs this Market cap would still make great earnings for shareholders."
I disagree. Now, at 1.4c (and closer to 1.3 than 1.5c) is not the best time to raise money for a couple of years, plus, it would require another EGM since the remaining CR cap at this price would not be enough to provide such cash runway.
My preference is to only raise enough to provide funds for 9 months max, which will likely require options attached but preferably with a higher strike price than our current SP (say 1 for 1 or 2 for 3 at 3c with an expiry of 12 months, which will then also result in additional funding down the track while reducing a CR dilution for existing shareholders at these ATL levels), given that we are expecting a few possible catalysts during that time:
That's from the July presentation:
https://www.listcorp.com/asx/chm/chimeric-therapeutics-limited/news/investor-presentation-3059704.html
But - likely also just things dreams are made of given our current situation.
- Forums
- ASX - By Stock
- Ann: 2024 Annual Report update
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

"Even a large dilution event now would be preferable if the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $69.79K | 17.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9548289 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.003 |
16 | 13800507 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9548289 | 12 |
0.005 | 14771167 | 22 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online